Bears, Beets, Rifaximin

Overview

Journal Can Liver J

Specialty Gastroenterology

Date 2022 Aug 22

PMID 35989893

Authors

Peter L Wang

Jennifer A Flemming

Affiliations

Soon will be listed here.

References

Sarwar S, Muhyuddin B, Aleem A, Nadeem M . Primary prophylaxis of hepatic encephalopathy in decompensated cirrhosis: Low dose vs. full dose rifaximin. Pak J Med Sci. 2019; 35(5):1446-1450. PMC: 6717468. DOI: 10.12669/pjms.35.5.549. View

Riggio O, Masini A, Efrati C, Nicolao F, Angeloni S, Salvatori F . Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol. 2005; 42(5):674-9. DOI: 10.1016/j.jhep.2004.12.028. View

Calanni F, Renzulli C, Barbanti M, Viscomi G . Rifaximin: beyond the traditional antibiotic activity. J Antibiot (Tokyo). 2014; 67(9):667-70. DOI: 10.1038/ja.2014.106. View

Bass N, Mullen K, Sanyal A, Poordad F, Neff G, Leevy C . Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010; 362(12):1071-81. DOI: 10.1056/NEJMoa0907893. View

Koo H, DuPont H . Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2009; 26(1):17-25. PMC: 4737517. DOI: 10.1097/MOG.0b013e328333dc8d. View

Bai M, Qi X, Yang Z, Yang M, Fan D, Han G . TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis. World J Gastroenterol. 2014; 20(10):2704-14. PMC: 3949280. DOI: 10.3748/wjg.v20.i10.2704. View

Mas A, Rodes J, Sunyer L, Rodrigo L, Planas R, Vargas V . Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. J Hepatol. 2002; 38(1):51-8. DOI: 10.1016/s0168-8278(02)00350-1. View

De Franchis R . Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015; 63(3):743-52. DOI: 10.1016/j.jhep.2015.05.022. View

Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen K . Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014; 60(2):715-35. DOI: 10.1002/hep.27210. View

10.

Bureau C, Thabut D, Jezequel C, Archambeaud I, DAlteroche L, Dharancy S . The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial. Ann Intern Med. 2021; 174(5):633-640. DOI: 10.7326/M20-0202. View